Ann Faust

Q: What is Ann Faust email address?

Email Ann Faust at ann.faust@novartis.com. This email is the most updated Ann Faust email found in 2026.

Q: How to contact Ann Faust?

To contact Ann Faust send an email to ann.faust@novartis.com. If you want to call Ann Faust try calling on +16174323290. (updated on October 29, 2024)

Senior Principal Scientist at Novartis Institutes for BioMedical Research (NIBR) | Cambridge, Massachusetts, United States

About Ann Faust

Ann Faust serves as a Senior Principal Scientist at the Novartis Institutes for BioMedical Research (NIBR), where she plays a pivotal role in advancing drug discovery through her expertise in cell-based toxicity assays and early predictive safety assessments. With a robust background in genetic engineering, molecular biology, and metabolic pathway engineering, Ann is at the forefront of developing innovative methodologies that enhance the predictive capabilities of safety evaluations in drug candidates. Her work focuses on integrating high-throughput screening techniques with sophisticated cell-based assays, allowing for more accurate predictions of drug toxicity and efficacy early in the discovery process.

At NIBR, Ann leads key projects that leverage her extensive knowledge in yeast and microbial cell biology to create synthetic platforms for drug testing. This includes the design and implementation of host strain construction projects that facilitate the rapid assessment of compound safety profiles. Her proficiency in molecular genetics and biochemistry enables her to develop and optimize assays that are not only reliable but also scalable, ensuring that they meet the rigorous demands of modern drug development.

In addition to her technical skills, Ann is recognized for her contributions to the scientific community through conference organization and scientific writing, where she shares insights on the latest advancements in drug discovery and predictive safety. Her meticulous approach and high level of accuracy in experimental design have made her a respected figure in the field, driving forward the mission of NIBR to deliver transformative therapies to patients. As she continues to push the boundaries of what is possible in early drug discovery, Ann remains committed to fostering collaboration and innovation within the industry.

Ann Faust Work